Trader consensus on Polymarket prices an 84.5% implied probability for no new WHO-designated COVID-19 variant of concern before 2027, driven by the absence of any VOC classifications since Omicron sublineages years ago, amid SARS-CoV-2's shift to endemic circulation. Recent emergence of BA.3.2 ("Cicada"), a highly mutated Omicron descendant designated only as a variant under monitoring on December 5, 2025, has fueled brief attention—spreading to over 30 U.S. states and 33 countries by mid-April 2026—but genomic surveillance shows no evidence of heightened transmissibility, severity, or vaccine evasion beyond low-level immune escape, with U.S. test positivity at 1.8% and 2025-2026 vaccines remaining protective. High population immunity from prior infections and boosters underpins this stability, though ongoing wastewater and global monitoring could flag surprises.